Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GHSR | Q92847 | 5/20 | 0.58 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.53 |
| ▸ | KISS1R | Q969F8 | 5/20 | 0.50 |
| ▸ | PCSK9 | Q8NBP7 | 1/20 | 0.49 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.49 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29866466 | 0.93 | GHSR (0.67) | GHSRUTS2R | |
| SCHEMBL31593374 | 0.91 | GHSR (0.64) | GHSRSLC15A2 | |
| SCHEMBL29630407 | 0.89 | UTS2R (0.61) | GHSRUTS2RKISS1R | |
| SCHEMBL29867952 | 0.89 | GHSR (0.62) | GHSR | |
| SCHEMBL30883343 | 0.86 | IL23R (0.55) | GHSRUTS2R | |
| SCHEMBL31593250 | 0.85 | GHSR (0.58) | GHSR | |
| SCHEMBL31593292 | 0.85 | GHSR (0.57) | GHSRKISS1RPCSK9SLC15A2PRMT1 | |
| SCHEMBL31593361 | 0.85 | ACE (0.59) | GHSR | |
| SCHEMBL30265193 | 0.84 | GHSR (0.55) | GHSRUTS2RPRMT1 | |
| SCHEMBL31606525 | 0.84 | GHSR (0.59) | GHSRUTS2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12618102-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited (GB) | 2026-05-05 | — | — | US | disclosed |
| US-20220112547-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12618102-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | POLM, POLR1A, POLR1E | GHSR 3273/4885UTS2R 2487/4885KISS1R 4118/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.